Associazione Nazionale Medici Cardiologi Ospedalieri

www.anmco.it

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
Impact of new multiparameter algorithm for the management of heart failure patients with an ICD in terms of reduced hospitalization and role of the Cardiology Technician in telecardiology related to specific heart failure service – our experience
Anno:
2024
Introduction Heart failure represents an important cause of hospitalization and is associated with an increased cardiovascular risk for the patient as well as an increase in healthcare spending. In recent years, algorithms for detecting pre-heart failure subclinical changes have been developed for implantable defibrillator (ICD) users so as to…
Leggi di più
PARTIALLY REVERSIBLE DILATED CARDIOMYOPATHY ASSOCIATED WITH AMPHOTERICIN B THERAPY
Anno:
2024
BACKGROUND Amphotericin B (AmB) is an antifungal drug commonly used in a broad spectrum of infections, including leishmaniasis. Leishmaniasis, transmitted through insect bites, has cutaneous, mucocutaneous, or visceral (particularly liver and spleen) involvement. The main adverse effects of AmB are cardiotoxicity and nephrotoxicity, often reversible, but with yet unclear…
Leggi di più
HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFpEF) IN A PATIENT WITH RECENT TAVI AND NUMEROUS CORONARY FISTULAS OF THE LEFT CORONARY ARTERY DRAINING INTO THE VENTRICULAR CAVITY
Anno:
2024
Coronary fistula is a rare form of congenital heart disease and is defined as an abnormal connection between a coronary branch and a cardiac chamber or a large intrathoracic vessel without the interposition of the capillary circulation. The right coronary artery is the most common site of origin for…
Leggi di più
A new project of a specific exercise protocolfor ambulatory cardiovascular rehabilitation specific for heart failure: report of the first experience
Anno:
2024
The indication to cardiovascular rehabilitation (CV rehab) was recently upgraded to I A in the European guidelines (GL) for the treatment of heart failure (HF), along with the four pharmacologic pillars. According to this change, we have implemented our CV rehab protocol to include specific exercises for patients (pts)…
Leggi di più
Taking a walk on the heart failure side: comparison of metabolic variables during walking and maximal exertion
Anno:
2024
Background: Background: Although cardiopulmonary exercise testing (CPET) is the gold standard to assess exercise capacity, simpler tests (i.e. 6-minute walk test, 6MWT) are also commonly used. Aim of this study was to evaluate the relationship between cardiorespiratory parameters during CPET and 6MWT in a large, multicenter, heterogeneous population. Methods:…
Leggi di più
MULTIDISCIPLINARY APPROACH TO A DIFFICULT CASE OF ACUTE HEART FAILURE DUE TO POSSIBILE ISOLATED CARDIAC SARCOIDOSIS
Anno:
2024
Background – Cardiac sarcoidosis (CS) is a rare, infiltrative cardiomyopathy that results from granulomatous inflammation affecting the heart with high morbidity and mortality. It is usually associated with a systemic (i.e. pulmonary) involvement, but lone heart involvement has been described. Even with extensive multidisciplinary evaluation making a firm diagnosis…
Leggi di più
Overcoming extreme medical-surgical events, in carriers of CRTD and CCM. Clinical stabilization.
Anno:
2024
A 63-year-old male patient suffering from chronic dilated ischemic heart disease, with severe depression of contractility and estimated EF of 16%, carrier of CRT-D and CCM, in follow up at our center. Extreme events of medical/surgical interest have occurred in the last period: the patient underwent strangulated hernia surgery…
Leggi di più
Safety of SGLT2 inhibitors in active cancer patients: Rationale and study design of TOSCA trial
Anno:
2024
Background: SGLT2 inhibitors have dramatically improved the outcome of heart failure patients with both preserved (HFpEF), mildly reduced (HFmrEF) and reduced (HFrEF) ejection fraction. Cancer patients have been excluded (or not enrolled) from pivotal trials so data on safety in such population are lacking. We aimed to collect evidence…
Leggi di più
QRS INDEX TO PREDICT CARDIAC RESYNCHRONIZATION THERAPY RESPONSE: A TRICENTRIC STUDY
Anno:
2024
BACKGROUND: Several studies have evaluated the role of QRS duration (QRSd) or QRS narrowing as a predictor of response to cardiac resynchronization therapy (CRT) to reduce non-responders. PURPOSE: The aim of our study was to determine the correlation between the relative change in QRS narrowing index (QI) compared to…
Leggi di più
The outpatient clinic for patients with heart failure: a proposal for advanced nursing.
Anno:
2024
In Italy, Heart Failure represents the leading cause of hospitalization in people over the age of sixty-five and is considered a public health problem of enormous importance, as it entails disabling consequences for the person, such as a significant reduction in the quality of life and the degree of…
Leggi di più

A.N.M.C.O. – Via La Marmora 36, 50121 Firenze (Italy) – Partita I.V.A. 05469530488 – Codice Fiscale 01301130488 – Privacy
www.anmco.it | segreteria@anmco.it

Cookie Policy Privacy Policy

Seguici su

Facebook Twitter Youtube Linkedin Instagram Telegram